Haydeh Payami helped uncover the genetic basis of Parkinson’s disease. Now, she hopes to find new ways to treat the disease by studying the gut microbiome.

A new study confirms reports of membrane-bound RNA molecules and points to their role in neutrophil migration.

This year’s Breakthrough Prizes honor advances in CAR T cancer therapies, cystic fibrosis, and Parkinson’s disease.

As much as rainforests or deep-sea vents, the human gut holds rich stores of microbial chemicals that should be mined for their pharmacological potential.

The approach could help test hypotheses about how atypical function of the brain’s immune cells contributes to autism.

We have barely scratched the surface of itch science and what it indicates about our health.

Several lines of evidence suggest that targeting the body’s defense pathways might help treat a subset of people with the psychiatric disorder. But many open questions remain.

Clinicians and researchers teamed up to investigate how inappropriate proinflammatory mechanisms contribute to the pathogenesis of drug-refractory epilepsy.

The world was rocked by the COVID-19 pandemic this year, but researchers rose to all manner of challenges.

Conversations between the immune and central nervous systems are proving to be essential for the healthy social behavior, learning, and memory.